Abstract
Serum calcitonin (CT) levels and other aspects of calcium metabolism were investigated in 40 epileptic children receiving long-term treatment with phenytoin and/or other anticonvulsant drugs, and in 38 age-matched controls. In the patients CT levels were significantly lower. Immunoreactive parathyroid hormone (iPTH) was significantly elevated exceeding the upper limit of controls in 11 patients. We also observed a highly significant correlation between iPTH and urinary cyclic AMP (cAMP) excretion but a lack of such a correlation with the renal handling of phosphate; this indicates to us a dissociation between cAMP production and phosphaturia. A significant correlation between iPTH levels and urinary hydroxyproline excretion points to a normal action of PTH on bone in the patients. The low CT levels are not due to hypocalcemia and may be directly attributed to the effects of anticonvulsant drugs. As the primary effect of CT is a direct inhibition of PTH induced calcium loss from bone, the drug-related low CT levels in association with secondary hyperparathyroidism possibly is an additional factor in anticonvulsant bone disease.
Similar content being viewed by others
References
Bonfils, P., Kuonen, E., Flückiger, J., Flury, W., Modler, J.: Veränderungen der Serumkonzentrationen von Calcium und anorganischem Phosphat sowie der Aktivität der alkalischen Phosphatase durch antiepileptische Behandlung. Schweiz. Med. Wschr. 106, 1109–1115 (1976)
Christiansen, C., Nielsen, S. P., Röbro, P.: Anticonvulsant hypomagnesaemia. Brit. Med. J. 1974 I, 198–199
Christiansen, C., Rödbro, P.: Anticonvulsant osteomalacia treated with different doses of vitamin D3 and 25-OH-D3. In: Vitamin D and problems related to uremic bone disease. Proceedings of the second workshop on Vitamin D, Wiesbaden, West Germany, October 1974, pp. 743–748
Deftos, L. J., Powell, D., Parthemore, J. G., Potts, J. T. Jr.: Secretion of calcitonin in hypocalcemic states in man. J. Clin. Invest. 52, 3109–3114 (1973)
Drezner, M., Neelon, F. A., Lebovitz, H. E.: Pseudohypoparathyroidism type II: A possible defect in the reception of the cyclic AMP signal. N. Engl. J. Med. 289, 1056–1060 (1973)
Hahn, T. J.: Bone complications of anticonvulsants. Drugs 12, 201–211 (1976)
Hahn, T. J., Hendin, B. A., Scharp, C. R., Boisseau, V. C., Haddad, J. G.: Serum 25-hydroxycalciferol levels and bone mass in children on chronic anticonvulsant therapy. N. Engl. J. Med. 292, 550–554 (1975)
Hausamen, T.-U., Helger, R., Rick, W., Gross, W.: Optimal conditions for the determination of serum alkaline phosphatase by a new kinetic method. Clin. Chim. Acta 15, 241–245 (1967)
Heath, H., III, Sizemore, G. W.: Plasma calcitonin in normal man: differences between men and women. J. Clin. Invest. 60, 1135–1140 (1977)
Hehrmann, R., Wilke, R., Nordmeyer, J. P., Hesch, R. D.: Hochsensitiver, C-terminal-spezifischer Radioimmunoassay für menschliches Parathormon als Routinemethode. Dtsch. Med. Wschr. 101, 1726–1729 (1976)
Heynen, G., Franchimont, P.: Human calcitonin radioimmunoassay in normal and pathological conditions. Europ. J. Clin. Invest. 4, 213–222 (1974)
Hillyard, C. J., Stevenson, J. C., McIntyre, I.: Relative deficiency of plasma-calcitonin in normal women. Lancet 1978 I, 961–962
Jubiz, W., Haussler, M. R., McCain, T. A., Tolman, K. G.: Plasma 1,25-dihydroxyvitamin D levels in patients receiving anticonvulsant drugs. J. Clin. Endocrinol. Metab. 44, 617–621 (1977)
Koch, H.-U., Kraft, D., von Herrath, D., Schaefer, K.: Influence of diphenylhydantoin and phenobarbital on intestinal calcium transport in the rat. Epilepsia 13, 829–834 (1972)
Langley, W. D., Evans, M.: The determination of creatinine with 3,5-dinitrobenzoate. J. Biol. Chem. 115, 333–341 (1935)
Lauffenburger, T., Olah, A. J., Dambacher, M. A., Guncaga, J., Lentner, C., Haas, H. G.: Bone remodeling and calcium metabolism: a correlated histomorphometric, calcium kinetic, and biochemical study in patients with osteoporosis and Paget's disease. Metabolism 26, 589–605 (1977)
McIntyre, I.: The action and control of the calcium-regulating hormones. J. Endocrinol. Invest. 1, 277–284 (1978)
Offermann, G., Pinto, V., Kruse, R.: Antiepileptic drugs and vitamin D supplementation. Epilepsia 20, 3–15 (1979)
Pento, J., T., Glick, S. M., Kagan, A.: Diphenylhydantoin inhibition of calcitonin secretion in the pig. Endocrinology 92, 330–333 (1973)
Raue, F., Minne, H., Streibl, W., Ziegler, R.: Calcitonin radioimmunoassay. Clinical application. In: “Radioimmunoassay and related procedures in medicine 1977”, Vol. II. International Atomic Energy Agency, Vienna, 1978, pp. 419–426
Rowe, D. J. F., Harris, M.: Effects of anticonvulsant drugs on bone resorption induced by parathyroid extract in vitro. In: Anticonvulsant drugs and enzyme induction, A. Richens, F. P. Woodford (eds.), pp. 113–121. Elsevier Excerpta Medica. North-Holland 1976
Stamp, T. C. B., Round, J. M., Rowe, D. J. F., Haddad, J. G.: Plasma levels and therapeutic effect of 25-hydroxycholecalciferol in epileptic patients taking anticonvulsant drugs. Brit. Med. J. 1972 IV, 9–12
Shainkin-Kerstenbaum, R., Funkenstein, B., Conforti, A., Shani, S., Berlyne, G. M.: Serum calcitonin and blood mineral interrelationships in normal children aged six to twelve years. Pediat. Res. 11, 112–116 (1977)
Tovey, K. C., Oldham, G. N., Whelan, J. A. M.: A simple direct assay of cyclic AMP in plasma and other biological samples using an improved competitive protein binding technique. Clin. Chim. Acta 56, 221–234 (1974)
Walton, R. J., Bijvoet, O. L. M.: Nomogram for derivation of renal threshold phosphate concentration. Lancet 1975 II. 309–310
Zamboni, G., Cecchettin, M., Albertini, A., Andreoli, A., Zoppi, G.: Parathyroid hormone and calcitonin levels in vitamin D deficient rickets. Europ. J. Pediat. 130, 137–145 (1979)
Author information
Authors and Affiliations
Additional information
Dedicated to Prof. Dr. H.-R. Wiedemann on the occasion of his 65th birthday
Rights and permissions
About this article
Cite this article
Kruse, K., Bartels, H., Ziegler, R. et al. Parathyroid function and serum calcitonin in children receiving anticonvulsant drugs. Eur J Pediatr 133, 151–156 (1980). https://doi.org/10.1007/BF00441584
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00441584